Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 2, 2010, Pages 310-316

  Mantsch, John R ^a   Wisniewski, Samantha ^a   Vranjkovic, Oliver ^a   Peters, Corey ^a   Becker, Amanda ^a   Valentine, Abbey ^a   Li, Shi Jiang ^b   Baker, David A ^a   Yang, Zheng ^c  

^a MARQUETTE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

7 OH DPAT; Antagonist; D2 receptor; D3 receptor; Discriminative stimulus; Dopamine; THP

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; SUCROSE; TETRAHYDROPALMATINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SELF ADMINISTRATION; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ADRENERGIC AGENTS; ANIMALS; BERBERINE ALKALOIDS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TETRAHYDRONAPHTHALENES;

RATTUS;

EID: 77957811262     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.08.016     Document Type: Article

References (57)

1. Acri J.B., Carter S.R., Alling K., Geter-Douglass B., Dijkstra D., Wikstrom H., et al. Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. Eur J Pharmacol 1995, 281:R7-R9.
2. Anderson S.M., Pierce R.C. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther 2005, 106:389-403.
3. Baker L.E., Svensson K.A., Garner K.J., Goodwin A.K. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. Eur J Pharmacol 1998, 358:101-109.
4. Barrett R.L., Appel J.B. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology 1989, 99:13-16.
5. Beardsley P.M., Sokoloff P., Balster R.L., Schwartz J.C. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behav Pharmacol 2001, 12:1-11.
6. Caine S.B., Koob G.F. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 1995, 6:333-347.
7. Caine S.B., Negus S.S., Mello N.K., Bergman J. Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Exp Clin Psychopharmacol 2000, 8:404-414.
8. Callahan P.M., Cunningham K.A. Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. J Pharmacol Exp Ther 1993, 266:585-589.
9. Callahan P.M., Appel J.B., Cunningham K.A. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 1991, 103:50-55.
10. Callahan P.M., De La Garza R., Cunningham K.A. Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 1997, 57:601-607.
11. Chausmer A.L., Katz J.L. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958, and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. Psychopharmacology 2002, 159:145-153.
12. Chu H., Jin G., Friedman E., Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol 2008, 28:491-499.
13. Costanza R.M., Barber D.J., Terry P. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists. Psychopharmacology 2001, 158:146-153.
14. De Smet P.A. Herbal remedies. N Engl J Med 2002, 347:2046-2056.
15. Depoortere R.Y., Li D.H., Lane J.D., Emmett-Oglesby M.W. Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol Biochem Behav 1993, 45:539-548.
16. Ding G.S. Important Chinese herbal remedies. Clin Ther 1987, 9:345-357.
17. Ernst E. The efficacy of herbal medicine-an overview. Fundam Clin Pharmacol 2005, 19:405-409.
18. Garner K.J., Baker L.E. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline. Pharmacol Biochem Behav 1999, 64:373-378.
19. Guo X., Wang L.M., Liu J., Jin G.Z. Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf-striatum. Zhongguo Yao Li Xue Bao 1997, 18:225-230.
20. Halbsguth C., Meissner O., Haberlein H. Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABAA binding site. Planta Med 2003, 69:305-309.
21. Hong Z., Fan G., Le J., Chai Y., Yin X., Wu Y. Brain pharmacokinetics and tissue distribution of tetrahydropalmatine enantiomers in rats after oral administration. Biopharm Drug Dispos 2006, 27:111-117.
22. Horowitz R.S., Feldhaus K., Dart R.C., Stermitz F.R., Beck J.J. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med 1996, 156:899-903.
23. Hu J.Y., Jin G.Z. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 1999, 20:715-719.
24. Huang K.X., Jin G.Z. The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. Sci China B 1992, 35:688-696.
25. Hubner C.B., Moreton J.E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 1991, 105:151-156.
26. Jin G.Z. (-)-Tetrahydropalmatine and its analogues as new dopamine receptor antagonists. Trends Pharmacol Sci 1987, 8:81-82.
27. Jin G.Z., Yu S.X., Yu L.P. Different effects of enantiomers of tetrahydropalmatine on dopaminergic system. Sci Sin 1986, 29:1054-1064.
28. Katz J.L., Witkin J.M. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey. Psychopharmacology 1993, 113:19-25.
29. Kleven M.S., Anthony E.W., Goldberg L.I., Woolverton W.L. Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390. Psychopharmacology 1988, 95:427-429.
30. Kleven M.S., Anthony E.W., Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 1990, 254:312-317.
31. Lamas X., Negus S.S., Nader M.A., Mello N.K. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology 1996, 124:306-314.
32. Lévesque D., Diaz J., Pilon C., Martres M.P., Giros B., Souil E., et al. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N, N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 1992, 89:8155-8159.
33. Lu Z.Z., Wei X., Jin G.Z., Han Q.D. Antagonistic effects of tetrahydroprotoberberine homologues on alpha-1 adrenoceptor. Yao Xue Xue Bao 1996, 31:652-656.
34. Mantsch J.R., Goeders N.E. Ketoconazole does not block cocaine discrimination or the cocaine-induced reinstatement of cocaine-seeking behavior. Pharmacol Biochem Behav 1999, 64:65-73.
35. Mantsch J.R., Li S.J., Risinger R., Awad S., Katz E., Baker D.A., et al. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology 2007, 192:581-591.
36. Martelle J.L., Claytor R., Ross J.T., Reboussin B.A., Newman A.H., Nader M.A. Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 2007, 321:573-582.
37. Platt D.M., Rowlett J.K., Spealman R.D. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 2002, 163:265-282.
38. Richardson N.R., Roberts D.C.S. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 1996, 66:1-11.
39. Roberts D.C., Loh E.A., Vickers G. Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 1989, 97:535-538.
40. Rowlett J.K., Platt D.M., Yao W.D., Spealman R.D. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 2007, 321:1135-1143.
41. Sinnott R.S., Mach R.H., Nader M.A. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys. Drug Alcohol Depend 1999, 54:97-110.
42. Sinnott R.S., Nader M.A. Modulation of cocaine's discriminative stimulus effects by dopamine D(1) agonists in rhesus monkeys. Pharmacol Biochem Behav 2001, 68:301-309.
43. Spealman R.D., Bergman J., Madras B.K., Melia K.F. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 1991, 258:945-953.
44. Spealman R.D. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 1996, 278:1128-1137.
45. Sun B.C., Huang K.X., Jin G.Z. Comparison of effects of tetrahydropalmatine enantiomers on firing activity of dopamine neurons in substantia nigra pars compacta. Zhongguo Yao Li Xue Bao 1992, 13:292-297.
46. Ukai M., Mitsunaga H. Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat. Methods Find Exp Clin Pharmacol 2005, 27:645-649.
47. Vanover K.E., Kleven M.S., Woolverton W.L. Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D(1) dopamine antagonists SCH-39166 and A-66359. Behav Pharmacol 1991, 2:151-159.
48. Vocci F.J., Acri J., Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry 2005, 162:1432-1440.
49. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 2004, 9:557-569.
50. Witkin J.M., Nichols D.E., Terry P., Katz J.L. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 1991, 257:706-713.
51. Wu G., Jiang J.W., Wu G.C., Cao X.D. Effects of four dopamine agonists on l-tetrahydropalmatine-induced analgesia and electroacupuncture analgesia in rabbits. Zhongguo Yao Li Xue Bao 1990, 11:196-200.
52. Xi Z.X., Gilbert J.G., Pak A.C., Ashby C.R., Heidbreder C.A., Gardner E.L. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur J Neurosci 2005, 21:3427-3438.
53. Xi Z.X., Newman A.H., Gilbert J.G., Pak A.C., Peng X.Q., Ashby C.R., et al. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 2006, 31:1393-1405.
54. Xi Z.X., Yang Z., Li S.J., Li X., Dillon C., Peng X.Q., et al. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropharmacology 2007, 53:771-782.
55. Xu S.X., Yu L.P., Han Y.R., Chen Y., Jin G.Z. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Zhongguo Yao Li Xuebao 1989, 10:104-110.
56. Yang Z., Shao Y.C., Li S.J., Qi J.L., Zhang M.J., Hao W., et al. Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. Acta Pharmacol Sin 2008, 29:781-788.
57. Zhu X.Z., Zhou Z., Ji X.Q., Gu J., Luo L.G., Wang F.S. l-tetrahydropalmatine increases leucine enkephalin levels in corpus striatum of rats. Zhongguo Yao Li Xue Bao 1991, 12:104-107.